Angiogenesis inhibitor	Antineoplastic agent	Monoclonal antibody	Vascular endothelial growth factor receptor antagonist
\|	\|	\|	\|

Bevacizumab (substance)
	Bevacizumab
	bevacizumab

Id	409406007
Status	Primitive

Has disposition	Angiogenesis inhibitor
Has disposition	Vascular endothelial growth factor receptor antagonist